Maersk Raises 2026 Earnings Outlook as Shipping Profits Beat Expectations 
Natura Q2 Profit Plunges 92% as Financial Expenses Weigh on Earnings 
England Drought Expands to 71% as Heatwave Deepens Water Crisis 
Gold Price Holds Near $4,400 as Hormuz Risks and CPI Drive Markets 
ANZ Home Loan Applications Drop 12% After Australia Property Tax Changes 
Australia Sets New Minimum Pay, Insurance Rules for Gig Workers 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Asian Stocks Rise as AI Chip Rally Lifts South Korea, Japan 
Canada, US Hold Fresh Trade Talks as August 19 Tariff Deadline Nears 
Japan Government Backs Earlier BOJ Rate Hike as Inflation Pressures Build 
Iran War Escalates as US, Houthis Target Ships Near Key Oil Routes 
European Stocks Rise as U.S. Inflation Data Eases Fed Rate Hike Fears 
Super Micro Stock Jumps 19% as AI Server Demand Drives Strong 2027 Outlook 
OpenAI Executive Brad Lightcap to Leave for New AI Venture 
CBA Posts Record A$10.98B Profit Despite Cautious Outlook 
Australia Housing Crisis Deepens as Worker Shortages Delay Homebuilding 
Hanwha Offers Up to $1.2 Billion for Austal US Business 
Add as a preferred source on Google
SK C&C has signed a deal with Microsoft Korea for cooperation in the advancement of AI cerebral hemorrhage solutions. The former is planning to register its imaging solution on Microsoft Azure for its healthcare platform.
SK C&C said it inked the memorandum of understanding (MOU) with Microsoft Korea on Thursday, Feb. 2. It has partnered with the American tech firm so it can expand into the global market for digital healthcare solutions. The IT services unit of the SK Group is also aiming to strengthen the industry ecosystem through the deal.
As per The Korea Economic Daily, under the agreement, the Medical Insight Plus Cerebral Hemorrhage imaging medical solution that was developed by SK C&C will be filed under the Microsoft Azure Healthcare neuroradiology category which is the company's cloud platform that specializes in healthcare.
Once registered, medical clinics that would like to make use of the solution can simply buy it from the Azure Marketplace. Buyers will also be able to receive follow-up services on the platform. SK C&C will also jump into the global market by working with the in-country sales organization of Microsoft company.
"Starting with Asia and Oceania, we will actively seek out various solutions for the global healthcare market as well as customized digital IT service markets in the medical field," SK C&C's Healthcare Group's head, Yoon Dong Joon, said.
Korea Biomed Review stated that SK C&C's Medical Insight+ Brain Hemorrhage is an AI-based cerebral hemorrhage imaging solution that assesses brain CT scan images. The solution can complete the analysis within seconds. Thus, doctors are immediately informed about any bleeding or abnormalities detected. The company said that the accuracy of the software is more than 98%
SK C&C further stressed that the imaging solution software has the ability to identify even the smallest bleeding that can be missed by professional neuro-head and neck radiologists.
